Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (91-100 of 270) with videos related to

Pageof 27
Sort By:
Drugs|May 17, 2013
Optimizing the use of aspirin for cardiovascular preventionRubén Casado-Arroyo, Carlos Sostres, Angel Lanas
Current Treatment Options in Gastroenterology|September 12, 2014
Prevention and Treatment of NSAID GastropathyCarla J Gargallo, Carlos Sostres, Angel Lanas
Best Practice & Research. Clinical Gastroenterology|May 1, 2012
Balancing the risk and benefits of low-dose aspirin in clinical practiceRubén Casado-Arroyo, Carla Gargallo, Angel Lanas Arbeloa
Therapeutic Advances in Gastroenterology|July 27, 2018
Progress and challenges in the management of diverticular disease: which treatment?Angel Lanas, Daniel Abad-Baroja, Aitor Lanas-Gimeno
World Journal of Gastroenterology|June 15, 2017
Colorectal cancer population screening programs worldwide in 2016: An updateMercedes Navarro, Andrea Nicolas, Angel Ferrandez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 25, 2012
One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept studyAngel Lanas, Julio Ponce, Angelo Bignamini, et al.
Pharmacological Research|May 27, 2009
Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trialsFlorent Richy, Carmelo Scarpignato, Angel Lanas, et al.
Organogenesis|August 8, 2014
Liver bioengineering: from the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effectsMireia Caralt, Enrique Velasco, Angel Lanas, et al.
Expert Opinion on Drug Safety|August 11, 2021
Gastrointestinal and cardiovascular adverse events associated with NSAIDsMaría-José Domper Arnal, Gonzalo Hijos-Mallada, Angel Lanas
Therapeutic Advances in Gastroenterology|May 31, 2018
Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, et al.
Pageof 27

Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
Drugs|May 17, 2013
Optimizing the use of aspirin for cardiovascular preventionRubén Casado-Arroyo, Carlos Sostres, Angel Lanas
Current Treatment Options in Gastroenterology|September 12, 2014
Prevention and Treatment of NSAID GastropathyCarla J Gargallo, Carlos Sostres, Angel Lanas
Best Practice & Research. Clinical Gastroenterology|May 1, 2012
Balancing the risk and benefits of low-dose aspirin in clinical practiceRubén Casado-Arroyo, Carla Gargallo, Angel Lanas Arbeloa
Therapeutic Advances in Gastroenterology|July 27, 2018
Progress and challenges in the management of diverticular disease: which treatment?Angel Lanas, Daniel Abad-Baroja, Aitor Lanas-Gimeno
World Journal of Gastroenterology|June 15, 2017
Colorectal cancer population screening programs worldwide in 2016: An updateMercedes Navarro, Andrea Nicolas, Angel Ferrandez, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 25, 2012
One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept studyAngel Lanas, Julio Ponce, Angelo Bignamini, et al.
Pharmacological Research|May 27, 2009
Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trialsFlorent Richy, Carmelo Scarpignato, Angel Lanas, et al.
Organogenesis|August 8, 2014
Liver bioengineering: from the stage of liver decellularized matrix to the multiple cellular actors and bioreactor special effectsMireia Caralt, Enrique Velasco, Angel Lanas, et al.
Expert Opinion on Drug Safety|August 11, 2021
Gastrointestinal and cardiovascular adverse events associated with NSAIDsMaría-José Domper Arnal, Gonzalo Hijos-Mallada, Angel Lanas
Therapeutic Advances in Gastroenterology|May 31, 2018
Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, et al.
Pageof 27